Weekly influenza surveillance overview, 9 March 2012 - week 9
Surveillance report
The 2011-2012 influenza season started later than recent seasons and has been without any clear geographic progression. The following points are noteworthy this week:
Medium or higher intensity has been reported by 18 countries and increasing trends by 11 countries. Bulgaria, Italy and Spain have reported decreasing trends for at least two weeks in a row and are therefore the first three European countries past their epidemic peak this season.
Of 1 606 sentinel specimens tested, 48.0% were positive for influenza virus, the first proper decline this year. Of these sentinel viruses, 91.4% were type A and 8.6% were type B. Only six were A(H1)pdm09 (<1%).
Since week 40/2011, 1 024 SARI cases , including 40 fatalities, have been reported by seven countries. Of these cases, 690 were related to influenza infection – 90% with A(H3), 5% with A(H1)pdm09 and 5% with B viruses.
No resistance to neuraminidase inhibitors (oseltamivir and zanamivir) has been reported so far this season.
Three European countries have now seen a peak in their national influenza season epidemics but the trend is still upward in a number of others. The epidemics remain dominated by A(H3) viruses, but B viruses seem to be on the increase recently.
Medium or higher intensity has been reported by 18 countries and increasing trends by 11 countries. Bulgaria, Italy and Spain have reported decreasing trends for at least two weeks in a row and are therefore the first three European countries past their epidemic peak this season.
Of 1 606 sentinel specimens tested, 48.0% were positive for influenza virus, the first proper decline this year. Of these sentinel viruses, 91.4% were type A and 8.6% were type B. Only six were A(H1)pdm09 (<1%).
Since week 40/2011, 1 024 SARI cases , including 40 fatalities, have been reported by seven countries. Of these cases, 690 were related to influenza infection – 90% with A(H3), 5% with A(H1)pdm09 and 5% with B viruses.
No resistance to neuraminidase inhibitors (oseltamivir and zanamivir) has been reported so far this season.
Three European countries have now seen a peak in their national influenza season epidemics but the trend is still upward in a number of others. The epidemics remain dominated by A(H3) viruses, but B viruses seem to be on the increase recently.
Publication file
120309-SUR-weekly-influenza-surveillance-overview.pdf
English (1.89 MB - PDF)Related content
Share this page